There are 2867 resources available
The role of KRAS inhibitor and other new treatment options in pancreatic cancer
Presenter: Eileen O'Reilly
Session: Lessons learned and new horizons and other hepatobiliary/pancreatic malignancies
Resources:
Slides
Webcast
How to target invisible melanoma cells
Presenter: Caroline Robert
Session: Is heterogeneity the limitation of precision oncology in melanoma?
Resources:
Slides
Webcast
CN15 - Individual factors leading to delay in diagnosis in patients with colorectal cancer and their illness perceptions
Presenter: Ümran Ege Tanrıkulu
Session: Health promotion, prevention, and screening
Resources:
Abstract
1484O - Deep learning predicts patients’ outcome and mutations from H&E slides in gastrointestinal stromal tumor (GIST)
Presenter: raul perret
Session: Proffered Paper session: Sarcoma
Resources:
Abstract
Slides
Webcast
659MO - Pembrolizumab with or without chemotherapy for first-line treatment of recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): 5-year results from KEYNOTE-048
Presenter: Makoto Tahara
Session: Mini Oral session: Head & neck cancer
Resources:
Abstract
Slides
Webcast
450O - Initial monotherapy results of a phase I first-in-human study of ULK1/2 inhibitor DCC-3116 alone and in combination with MAPK pathway inhibition
Presenter: Anthony Tolcher
Session: Proffered Paper session: Developmental therapeutics
Resources:
Abstract
Slides
Webcast
134O - Dose-dense adjuvant chemotherapy in early-stage breast cancer patients: End-of-study results from a randomised, phase III trial of the Gruppo Italiano Mammella (GIM)
Presenter: Lucia Del Mastro
Session: Proffered Paper session: Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
Challenges in de-escalation trials
Presenter: Hendrik van Halteren
Session: De-escalation of treatment in medical oncology
Resources:
Slides
Webcast
LBA74 - Genomic biomarkers in peripheral blood (PB) from patients (pts) enrolled in the JAVELIN Bladder 100 trial of avelumab first-line (1L) maintenance in advanced urothelial carcinoma (aUC)
Presenter: Thomas Powles
Session: Proffered Paper session 1: GU tumours, non-prostate
Resources:
Abstract
Slides
Webcast
Conclusions and perspectives
Presenter: Zofia Piotrowska
Session: Slicing the pie: Advances in targeted therapy for oncogene-addicted NSCLC
Resources:
Slides
Webcast